Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Pierre Bertault Peres"'
Autor:
Patrick Thevin, Christophe Curti, Alexandre Benech, Christophe Jean, Edouard Lamy, Caroline Castera Ducros, Nicolas Primas, Pierre Bertault-Peres, Patrice Vanelle
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0282164 (2023)
ObjectiveErythromycin is a macrolide antibiotic that is also prescribed off-label in premature neonates as a prokinetic agent. There is no oral formulation with dosage and/or excipients adapted for these high-risk patients.MethodsClinical studies of
Externí odkaz:
https://doaj.org/article/f97cb661961341bb8466362f7c3e1949
Autor:
Bertrand Audoin, Marjorie Roudot, Stéphane Honoré, Adil Maarouf, Thomas Perez, Audrey Rico, Clemence Boutiere, Pierre Bertault-Peres, Jean Pelletier
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, 2021, 27 (4), pp.585-592. ⟨10.1177/1352458520912170⟩
Multiple Sclerosis Journal, 2021, 27 (4), pp.585-592. ⟨10.1177/1352458520912170⟩
Background: Rituximab’s originator MabThera® or Rituxan® has demonstrated high efficacy in multiple sclerosis (MS). Because of the patent expiration, rituximab biosimilars have been developed. However, because a biosimilar is not the exact copy o
Autor:
Thibaut, Brandin, Maya, Wasilewski, Camille, Panuccio, Cyrielle, Bouguergour, Nicolas, Primas, Edouard, Lamy, Christophe, Jean, Pierre, Bertault-Peres, Pascal, Rathelot, Christophe, Curti, Patrice, Vanelle
Publikováno v:
International journal of pharmaceutical compounding. 26(2)
Fludrocortisone acetate is a drug used to treat adrenal insufficiencies which can be prescribed to hospitalized or ambulatory pediatric patients at dosages not commercially available. For these patients, 10-µg fludrocortisone capsules are currently
Beyond-Use Dates Assignment for Pharmaceutical Preparations: Example of Low-Dose Amiodarone Capsules
Autor:
Patrice Vanelle, Christophe Jean, Edouard Lamy, Julie Broggi, Christophe Curti, Pierre Bertault-Peres, Damien Brun, Guillaume Tintori
Publikováno v:
J Pharm Technol
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2021, 37 (4), pp.178--185. ⟨10.1177/87551225211015566⟩
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians, 2021, 37 (4), pp.178--185. ⟨10.1177/87551225211015566⟩
Background: Beyond-use dates (BUDs) in compounding practice are assigned from stability studies. The United States Pharmacopoeia (USP 42 NF 37) suggested to assign a 6 months BUD for dry oral forms. A new pediatric formula of amiodarone capsules was
Autor:
Thomas, Perez, Audrey, Rico, Clémence, Boutière, Adil, Maarouf, Marjorie, Roudot, Stéphane, Honoré, Jean, Pelletier, Pierre, Bertault-Peres, Bertrand, Audoin
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 27(4)
Rituximab's originator MabTheraTo compare the efficacy and safety of the biosimilar TruximaConsecutive MS patients receiving MabTheraIn total, 105 and 40 patients received MabTheraThe efficacy and safety of the rituximab biosimilar Truxima
Autor:
Stéphane Honoré, Pierre Bertault-Peres, Laurent Boyer, Marie-Anne Esteve, Pascal Auquier, Pierre Renaudin
Publikováno v:
British Journal of Clinical Pharmacology. 82:1660-1673
AimsThe aim of this meta-analysis is to examine the impact of a in-hospital pharmacist-led medication reviews in paediatric and adult a patients. a MethodsRelevant studies were identified from the Medline and Cochrane a Library databases. Studies wer
Autor:
Raphaelle Fanciullino, Petula Vigne, Bertrand Pourroy, Amaury Guedon, Pierre Bertault Peres, Laurence Gauthier-Villano, Théau Du Repaire
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 74(16)
Blinatumomab is a bispecific T-cell engager antibody construct that binds specifically to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells.[1][1] Blinatumomab was approved by the European Medicine
Autor:
Pierre Bertault-Peres, Marjorie Legrand, Philippe Boutier, Marjorie Roudot, Thomas Perez, Alexandre Bacci, Florian Correard
Publikováno v:
Revue Neurologique. 175:S80
Introduction L’arrivee des biosimilaires permet des economies pour les systemes de sante et leurs efficacites commencent a convaincre les experts. Cependant, rien dans la litterature n’atteste de leurs efficiences dans des indications hors AMM, e
Autor:
Amaury, Guédon, Angélique, Rome, Jean-Laurent, Deville, Michael, Besse, Ludivine, Blanchet, Amandine, Savry, Laurence, Gauthier-Villano, Pierre, Bertault-Peres, Bertrand, Pourroy
Publikováno v:
American journal of medical quality : the official journal of the American College of Medical Quality. 32(2)
Autor:
Pierre, Renaudin, Laurent, Boyer, Marie-Anne, Esteve, Pierre, Bertault-Peres, Pascal, Auquier, Stéphane, Honore
Publikováno v:
British journal of clinical pharmacology. 82(6)
The aim of this meta-analysis is to examine the impact of in-hospital pharmacist-led medication reviews in paediatric and adult patients.Relevant studies were identified from the Medline and Cochrane Library databases. Studies were included if they m